The Vacuolar Protein Sorting (VPS) pathway was first characterized in yeast through genetic screens for mutants affecting vacuolar protein sorting. These screens identified VPS4 as a key gene required for normal vacuolar enzyme delivery. mammalian homologs were subsequently identified and characterized. The discovery of VPS4A as a human gene followed, with initial studies establishing its role in endosomal sorting and multivesicular body (MVB) formation. Subsequent research has expanded our understanding of VPS4A's roles in neuronal function and neurodegeneration, with genetic variants now implicated in Charcot-Marie-Tooth disease and other neurological conditions. The connection between ESCRT (Endosomal Sorting Complex Required for Transport) dysfunction and neurodegenerative diseases has become increasingly clear, placing VPS4A at the intersection of membrane trafficking and neuronal survival.
| Attribute | Value |
|---|---|
| Symbol | VPS4A |
| Full Name | Vacuolar Protein Sorting 4 Homolog A |
| Chromosomal Location | 16q22.1 |
| NCBI Gene ID | 27183 |
| OMIM | 609434 |
| Ensembl ID | ENSG00000167842 |
| UniProt ID | Q9Y5X0 |
| Protein Class | AAA+ ATPase |
| Associated Diseases | Charcot-Marie-Tooth Disease, ALS, FTD, Breast Cancer |
VPS4A (Vacuolar Protein Sorting 4 Homolog A) encodes an AAA+ ATPase involved in endosomal sorting, multivesicular body formation, and autophagy. It plays critical roles in membrane protein trafficking and has been implicated in neurodegenerative diseases. The protein functions as part of the ESCRT (Endosomal Sorting Complex Required for Transport) machinery, which is essential for membrane budding and scission events throughout the cell.
The VPS4A gene spans approximately 21 kb on chromosome 16q22.1 and encodes a 437-amino acid protein with a molecular weight of approximately 48 kDa. The protein adopts the typical AAA+ ATPase fold, consisting of an N-terminal MIT (Microtubule Interacting and Transport) domain, a central ATPase domain, and a C-terminal region involved in oligomerization.
| Domain | Amino Acids | Function |
|---|---|---|
| MIT domain | 1-75 | Endosomal binding, ESCRT-III interaction |
| ATPase domain | 150-350 | ATP hydrolysis, conformational change |
| C-terminal | 350-437 | Oligomerization, regulation |
The AAA+ ATPase domain contains the classic Walker A (P-loop) and Walker B motifs required for ATP binding and hydrolysis. ATP hydrolysis provides the energy for conformational changes that drive membrane scission events.
VPS4A belongs to the AAA+ (ATPase Associated with various cellular Activities) superfamily, which includes proteins involved in diverse cellular processes:
| Protein | Function | Disease Relevance |
|---|---|---|
| VPS4A | Endosomal sorting | CMT, ALS |
| VPS4B | ESCRT function | Lysosomal storage |
| NSF | SNARE recycling | Synaptic function |
| Spastin | ER dynamics | Hereditary spastic paraplegia |
| Mitochondrialdynamics | Mitochondrial fission | Neuropathy |
VPS4A functions as part of the ESCRT (Endosomal Sorting Complex Required for Transport) machinery, which consists of multiple protein complexes (ESCRT-0, -I, -II, -III) and associated proteins including VPS4A and VPS4B [1]. The ESCRT machinery is responsible for sorting cargo proteins into intralumenal vesicles of multivesicular bodies (MVBs), a process essential for lysosomal degradation of membrane proteins.
The ESCRT pathway operates as follows:
Multivesicular bodies (MVBs) are late endosomal compartments that contain intralumenal vesicles. MVB formation is essential for sorting cargo to lysosomes for degradation. VPS4A plays a critical role in the final stages of MVB formation [2]:
Early endosome → Cargo sorting → ESCRT recruitment → MVB formation
↓
VPS4A-mediated scission → Intralumenal vesicle release
↓
Late MVB → Lysosomal fusion → Degradation
The scission reaction releases nascent vesicles into the MVB lumen. VPS4A's ATPase activity provides the energy for this process, and defects in VPS4A function impair MVB formation and cargo sorting.
VPS4A also plays important roles in autophagy, the process by which cells degrade and recycle cytoplasmic components. Autophagy is particularly important in neurons due to their post-mitotic nature and high metabolic demands [3]:
The ESCRT machinery, including VPS4A, is required for budding of many enveloped viruses. This has made viral budding a key model system for understanding VPS4A function. Importantly, viral budding does not require the full ESCRT machinery, instead relying on viral proteins that mimic ESCRT functions [@hiv bud2011].
VPS4A exhibits broad expression throughout the body with particular importance in tissues requiring high membrane trafficking activity:
In neurons, VPS4A is enriched in:
VPS4A localization is dynamic, changing in response to neuronal activity. Synaptic activation can alter VPS4A trafficking and function.
Receptor activation → Endocytosis → Early endosome → MVB → Lysosome
↓
ESCRT machinery → VPS4A → Recycling
Stress/Starvation → Autophagosome → VPS4A function → Autolysosome
VPS4A participates in synaptic vesicle retrieval through endosomal sorting pathways. Recycling of synaptic vesicle proteins requires proper endosomal function, and VPS4A deficiency impairs this process [4].
VPS4A mutations have been associated with axonal forms of Charcot-Marie-Tooth disease (CMT2), characterized by peripheral neuropathy with motor and sensory deficits [5]:
The connection between VPS4A and CMT highlights the importance of membrane trafficking in long peripheral axons, which rely heavily on axonal transport.
Multiple lines of evidence connect VPS4A to ALS pathogenesis [@als2013; @müller2014]:
Huntington's Disease
VPS4A represents a potential therapeutic target for multiple conditions:
Small Molecule Modulators
Biological Approaches
VPS4A interacts with several key proteins:
| Interactor | Function | Interaction Type |
|---|---|---|
| CHMP2B | ESCRT-III | Direct binding |
| CHMP4B/C | ESCRT-III | Direct binding |
| ALIX | ESCRT accessory | Indirect |
| UBPY | Deubiquitinating enzyme | Regulation |
| Spartin | Atlastin regulation | Indirect |
Hanson et al. ESCRT function in neurons (2008). Nature Reviews Neuroscience. 2008. ↩︎ ↩︎
Hanson et al. Multivesicular body formation (2010). Journal of Cell Biology. 2010. ↩︎ ↩︎
Eskelinen et al. VPS4A in autophagy (2016). Autophagy. 2016. ↩︎ ↩︎
Kennedy et al. VPS4A in synaptic function (2022). Neuron. 2022. ↩︎ ↩︎
Lupas et al. CMT2A and VPS4A (2014). Neurology. 2014. ↩︎ ↩︎
Riffe et al. VPS4A and TDP-43 (2017). Molecular Neurodegeneration. 2017. ↩︎ ↩︎
Skibinski et al. Endosomal trafficking in ALS (2005). 2005. ↩︎
Hanson et al. ESCRT and neurodegeneration (2012). 2012. ↩︎
Urwin et al. VPS4A in ALS pathogenesis (2013). Brain. 2013. ↩︎
Zhang et al. VPS4A and exosome release (2019). Journal of Extracellular Vesicles. 2019. ↩︎
Settembre et al. VPS4A and lysosomal trafficking (2020). Nature Cell Biology. 2020. ↩︎
Raiborg et al. VPS4A in cell signaling (2021). Trends in Cell Biology. 2021. ↩︎
Chen et al. ESCRT-targeted therapy (2023). Molecular Therapy. 2023. ↩︎